Epigenetic modifications of histones in cancer
Z Zhao, A Shilatifard - Genome biology, 2019 - Springer
The epigenetic modifications of histones are versatile marks that are intimately connected to
development and disease pathogenesis including human cancers. In this review, we will …
development and disease pathogenesis including human cancers. In this review, we will …
Carcinogenesis: Failure of resolution of inflammation?
A Fishbein, BD Hammock, CN Serhan… - Pharmacology & …, 2021 - Elsevier
Inflammation in the tumor microenvironment is a hallmark of cancer and is recognized as a
key characteristic of carcinogens. However, the failure of resolution of inflammation in …
key characteristic of carcinogens. However, the failure of resolution of inflammation in …
Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer
Sex bias exists in the development and progression of nonreproductive organ cancers, but
the underlying mechanisms are enigmatic. Studies so far have focused largely on sexual …
the underlying mechanisms are enigmatic. Studies so far have focused largely on sexual …
JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA
Z Ni, P Sun, J Zheng, M Wu, C Yang, M Cheng, M Yin… - Cancer research, 2022 - AACR
The RNA N6-methyladenosine (m6A) writer methyltransferase-like 3 (METTL3) is
upregulated in many types of cancer and promotes cancer progression by increasing …
upregulated in many types of cancer and promotes cancer progression by increasing …
COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer
RJ Fagan, AK Dingwall - Cancer letters, 2019 - Elsevier
The KMT2 (lysine methyltransferase) family of histone modifying proteins play essential
roles in regulating developmental pathways, and mutations in the genes encoding these …
roles in regulating developmental pathways, and mutations in the genes encoding these …
Pparg signaling controls bladder cancer subtype and immune exclusion
Pparg, a nuclear receptor, is downregulated in basal subtype bladder cancers that tend to
be muscle invasive and amplified in luminal subtype bladder cancers that tend to be non …
be muscle invasive and amplified in luminal subtype bladder cancers that tend to be non …
UTX mutations in human cancer
L Wang, A Shilatifard - Cancer cell, 2019 - cell.com
Ubiquitously transcribed tetratricopeptide repeat on chromosome X (UTX, encoded by
KDM6A) is a histone demethylase that targets di-and tri-methylated histone H3 lysine 27 …
KDM6A) is a histone demethylase that targets di-and tri-methylated histone H3 lysine 27 …
Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances
L Zhao, S Jin, S Wang, Z Zhang, X Wang… - … and Targeted Therapy, 2024 - nature.com
Tertiary lymphoid structures (TLSs) are defined as lymphoid aggregates formed in non-
hematopoietic organs under pathological conditions. Similar to secondary lymphoid organs …
hematopoietic organs under pathological conditions. Similar to secondary lymphoid organs …
Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma
The long-term survival of patients with advanced urothelial carcinoma (UCa) is limited
because of innate resistance to treatment. We identified elevated expression of the histone …
because of innate resistance to treatment. We identified elevated expression of the histone …
Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions
Sex and gender disparities in bladder cancer have long been a subject of interest to the
cancer research community, wherein men have a 4 times higher incidence rate than women …
cancer research community, wherein men have a 4 times higher incidence rate than women …